![](/img/cover-not-exists.png)
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
Kashiwagi, Atsunori, Kazuta, Kenichi, Yoshida, Satoshi, Nagase, ItsuroVolume:
5
Language:
english
Journal:
Journal of Diabetes Investigation
DOI:
10.1111/jdi.12156
Date:
July, 2014
File:
PDF, 411 KB
english, 2014